American Journal of Preventive Medicine最新文献

{"title":"Minimum wage policies and obstetric disorders in the U.S.","authors":"Mark E McGovern, Slawa Rokicki, Hyunji Ahn, Nancy Reichman","doi":"10.1016/j.amepre.2025.108156","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108156","url":null,"abstract":"<p><strong>Introduction: </strong>Hypertensive disorders of pregnancy are a major public health problem in the US, with high rates among disadvantaged communities. This study examined the impact of minimum wage (MW) policies on hypertensive and other obstetric disorders in a population-based setting.</p><p><strong>Methods: </strong>This study used U.S. national, state-level data from the 1992-2019 Global Burden of Disease study to estimate associations between changes in state-level MWs and the incidence of maternal hypertensive and other obstetric disorders. Generalized difference-in-differences models were implemented. Analysis was performed January - July 2025.</p><p><strong>Results: </strong>The mean incidence of maternal hypertensive disorders was 410 cases per 100,000 women. In fully adjusted two-way fixed effects models, a $1 or greater increase in the MW was associated with a reduction in the incidence of maternal hypertensive disorders of 64.1 per 100,000 women (95% CI -108.6,-19.7) over 5 years. Results were consistent across a variety of estimation strategies, including two-way fixed effects and alternative approaches designed to account for staggered policy implementation.</p><p><strong>Conclusions: </strong>Findings suggest that MW policies may play a role in reducing maternal hypertensive disorders. Further research is needed using individual-level data to explore effect heterogeneity and examine subgroup impacts by race and ethnicity.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108156"},"PeriodicalIF":4.5,"publicationDate":"2025-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Public Support for Cancer-related Warning Labels on Alcohol Containers.","authors":"Emma Jesch, David Berrigan, William M P Klein","doi":"10.1016/j.amepre.2025.108151","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108151","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108151"},"PeriodicalIF":4.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"What About Vaccine-Experienced Younger Adults? Cost-Effectiveness of PCV21 Use in Vaccine-Experienced US Adults Aged 19-64 Years with Underlying Medical Conditions.","authors":"Zinan Yi, Elamin H Elbasha, Kwame Owusu-Edusei","doi":"10.1016/j.amepre.2025.108159","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108159","url":null,"abstract":"<p><strong>Background: </strong>Because of the residual pneumococcal disease burden among vaccineexperienced adults aged 19-64 years with underlying medical conditions in the United States (US), the Advisory Committee on Immunization Practices (ACIP) recommended revaccination with higher valent pneumococcal conjugate vaccine (PCV). Following PCV21's 2024 introduction, it was added as an option. This study evaluated the cost‑effectiveness of PCV21 versus the recommended alternatives (PPSV23, PCV15, and PCV20) in this population.</p><p><strong>Methods: </strong>A published static multi-cohort state-transition Markov model was used to estimate the lifetime incremental clinical and societal economic outcomes of administering a single dose of PCV21 in adults aged 19-64 years who were previously vaccinated 5 years ago with PPSV23 or PCV13, or 2 years ago with PCV15. The estimated total quality-adjusted life years (QALYs) and costs (in 2023 USD) were discounted at an annual rate of 3%, as well as the incremental cost-effectiveness ratios (ICERs) reported as $/QALY gained. Probabilistic/Deterministic sensitivity analysis (PSA/DSA) and scenario Analysis was conducted.</p><p><strong>Results: </strong>Among 19-49 year-olds, compared with PPSV23, the ICER of PCV21 in the PCV13- and PCV15-experienced adults was $99,700 and $149,300, respectively. PCV21 was cost-saving versus PCV15 in the PPSV23-experienced and versus PCV20 across all vaccine-experienced population. Among 50-64 year-olds, compared with PPSV23, the ICER of PCV21 was $62,400/QALY in PCV13-experienced and $85,400 in PCV15-experienced. PCV21 was cost-saving compared with PCV15 or with PCV20 across all vaccine-experienced population. The DSA identified that discount rates and vaccine effectiveness were the most influential inputs. The PSA confirmed the results' robustness. The scenario analysis showed only minor changes in ICER when the time since last vaccination extended to 8 years for the PPSV23 or PCV13-experienced younger adults.</p><p><strong>Conclusions: </strong>The use of PCV21 in US adults aged 19-64 years with underlying medical conditions can be cost-effective, or cost-saving in most cases, across a wide range of scenarios.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108159"},"PeriodicalIF":4.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Moderating effect of participation in organized college sports on mental health and frequency of cannabis use in a national cohort.","authors":"Joanna S Zeiger, Bradley T Conner","doi":"10.1016/j.amepre.2025.108148","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108148","url":null,"abstract":"<p><strong>Introduction: </strong>Research has shown positive associations between cannabis use and psychological distress. This study examines relations cannabis use and diagnoses of depression, anxiety, and PTSD, while exploring the moderating role of organized sports (OS).</p><p><strong>Methods: </strong>Data came from the National College Health Assessment III Fall 2019-Fall 2023, analyzed in 2024. Participants (n=150,992) were mostly aged 18-29 years (87.5%), biologically female (70.3%), and non-Hispanic White (72.3%).</p><p><strong>Results: </strong>Higher cannabis use frequency was associated with a greater likelihood of lifetime diagnosis of depression, anxiety, and PTSD, with the highest prevalence observed among those reporting weekly to daily cannabis use (p<0.001). OS participation was associated with significantly lower rates of lifetime diagnoses (p<0.001) and moderated the relation between cannabis use and diagnosis. Among OS participants, the prevalence of reported lifetime mental health conditions was lower across cannabis use compared to non-OS participants (p<0.001).</p><p><strong>Conclusions: </strong>These findings highlight the protective role of OS in reducing mental health risks associated with cannabis use. Encouraging sports participation in college may enhance mental well-being and address substance use challenges as part of comprehensive health strategies.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108148"},"PeriodicalIF":4.5,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Linkage to substance use disorder treatment through syringe services programs and the criminal legal system: A Cross-Sectional Study.","authors":"Leslie W Suen, Cariné E Megerian, Erica N Browne, Esther O Chung, Christopher F Akiba, Jason Williams, Jamie L Humphrey, Lynn D Wenger, Bradley Ray, Barrot H Lambdin, Alex H Kral","doi":"10.1016/j.amepre.2025.108150","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108150","url":null,"abstract":"<p><strong>Introduction: </strong>Evidence on how two approaches-syringe services programs (SSP) and criminal legal system (CLS) interventions-are associated with substance use disorder (SUD) treatment is needed to inform SUD treatment policies. This paper examines the associations between SSP utilization and CLS involvement with SUD treatment.</p><p><strong>Methods: </strong>This cross-sectional study recruited 835 people who use drugs from September 2023 to September 2024 in San Francisco, California, and surveyed their substance use, medical, social, and harm reduction services utilization, and CLS involvements. Past 3-month associations between any SSP use and any CLS involvement with any SUD treatment were examined.</p><p><strong>Results: </strong>The sample comprised 770 participants. Median [range] age was 42.5 years (19-80); 67% men, 28% women, and 5% gender-expansive; 34% Black or African American, 19% Hispanic or Latine, and 57% White. Most (78%) reported recent SSP use, and 48% reported any CLS involvement. About a quarter (27%) reported any recent SUD treatment. Multivariable analyses adjusting for age, Black race, and housing status, found that individuals with recent SSP use had higher probability of recent SUD treatment (adjusted prevalence ratio [APR] 1.77, 95% CI 1.23-2.54, p=0.002), while individuals with recent CLS involvement had similar probability of SUD treatment as those who did not (APR 1.00, 95% CI 0.78-1.28, p=0.99).</p><p><strong>Conclusions: </strong>Findings suggest that recent SSP use was associated with recent SUD treatment uptake, while recent CLS involvement was not. These findings underscore that SSPs remain a vital component linking people who use drugs into SUD treatment.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108150"},"PeriodicalIF":4.5,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"THE PARK RX RANDOMIZED CONTROLLED TRIAL (RCT): IMPACT ON PHYSICAL ACTIVITY (PA) AMONG YOUTH.","authors":"Deborah A Cohen, Robert Zarr, Erika Estrada, Haoyuan Zhong, Bing Han","doi":"10.1016/j.amepre.2025.108154","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108154","url":null,"abstract":"<p><strong>Introduction: </strong>Most youth do not achieve recommended levels of physical activity (PA), so finding methods to increase PA would be beneficial to health. The objective of this study was to determine if clinician prescriptions for park visits would increase PA among youth.</p><p><strong>Study design: </strong>This randomized clinical trial (RCT) was conducted from 2020-2023 with 12-months follow-up.</p><p><strong>Setting/participants: </strong>This RCT was conducted in a Federally Qualified Health Center outpatient clinic in Washington, DC and focused on youth ages 6-16 with one or more diagnoses of chronic conditions that usually require two or more routine health care provider visits per year.</p><p><strong>Intervention: </strong>Receiving park prescriptions from their health care provider during regular clinic visits, about every 3 months.</p><p><strong>Main outcome measures: </strong>Accelerometry-measured minutes of moderate-to-vigorous physical activity (MVPA), BMI, blood pressure (BP) and self-report of park visit frequency and time spent in park were measured.</p><p><strong>Results: </strong>Of the 514 randomized participants, the median age was 10.4 yrs (SD 2.7) and included 246 females (47.9%), 268 males, (52.1%) 451 Latinx (87.7%), and 52 African Americans (10.1%). Intent-to-treat analyses showed a significant change of daily MVPA, increasing 2.03.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108154"},"PeriodicalIF":4.5,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Kennedy v Braidwood and weight management preventive services: A renewed opportunity for improved health.","authors":"Nina E Hill, A Mark Fendrick","doi":"10.1016/j.amepre.2025.108153","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108153","url":null,"abstract":"<p><p>Kennedy v Braidwood is a recent legal challenge to the Affordable Care Act (ACA) preventive services coverage provision that requires specific preventive services to be provided without patient cost sharing. The Supreme Court of the United States fortunately upheld the constitutionality of the ACA preventive services coverage. This case has important implications across a range of services recommended by the U.S. Preventive Services Task Force (USPSTF), including those addressing weight management. The USPSTF recommends several effective behavioral counseling interventions to prevent or address excess weight. The populations affected include pregnant women, children and adolescents, and adults with cardiovascular disease risk factors. Protection of the ACA preventive services coverage provision provides a renewed opportunity to improve critical preventive health services that significantly improve the health of millions of Americans.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108153"},"PeriodicalIF":4.5,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemiology of Cannabis Use Among Middle-Aged and Older Adults in the United States.","authors":"Ofir Livne, Malka Stohl, Jodi Gilman, Terry E Goldberg, Melanie M Wall, Deborah S Hasin","doi":"10.1016/j.amepre.2025.108149","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108149","url":null,"abstract":"<p><strong>Introduction: </strong>The prevalence of medical cannabis use, consumption methods, other key cannabis behaviors, and attitudes toward use is understudied, and associations with any cannabis use among US middle-age and older adults is of particular interest since they are especially vulnerable to the adverse effects of cannabis.</p><p><strong>Methods: </strong>Health and Retirement Study data (n=1,324) was analyzed, calculating weighted prevalences for cannabis measures, including past-year use, consumption methods, medical use, health conditions for which cannabis was used, healthcare provider recommendations, attitudes toward acceptability, risks, and legalization, by primary age groups (50-64, ≥65) and specified older age groups (65-74, ≥75) and sex. Associations with any cannabis use were evaluated using multivariable logistic regression, adjusting for sex, race/ethnicity, household income, and employment.</p><p><strong>Results: </strong>Past year cannabis use in the U.S. was reported by 18.5% and 5.9% of middle-age and older adults, respectively. Smoking was the primary consumption method in both groups. Approximately 25% of middle-aged adults and 20% of older adults who used cannabis consumed it for medical purposes, with ∼20% of those receiving a prescription or recommendation. Over 75% of individuals in both age groups viewed medical use as acceptable, and older adults were more likely to view cannabis as a gateway drug and to support restrictions of cannabis laws.</p><p><strong>Conclusions: </strong>Cannabis use among both middle-aged and older U.S. adults is higher than previously reported in state- and national-level studies, with many engaging in cannabis behaviors associated with increased harm. Greater public health and clinical efforts are needed for tailored prevention and intervention strategies.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108149"},"PeriodicalIF":4.5,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Illicit drug use during pregnancy in states with and without punitive prenatal substance use policies.","authors":"Anna E Austin, Laura C Hergenrother, Meghan E Shanahan","doi":"10.1016/j.amepre.2025.108155","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108155","url":null,"abstract":"<p><strong>Introduction: </strong>An increasing number of states have implemented punitive prenatal substance use policies. These include policies that consider prenatal substance use as grounds for substantiating abuse and neglect or for terminating parental rights (i.e., child abuse policies) and policies that require healthcare professionals to report prenatal substance use to child protective services (i.e., mandated reporting policies). Little research has examined whether these policies reduce substance use during pregnancy. The aim of this study was to examine the association of punitive state prenatal substance use policies with illicit drug use during pregnancy.</p><p><strong>Methods: </strong>Data from 19 states' 2016-2019 Pregnancy Risk Assessment Monitoring System (PRAMS) survey (N= 20,356) were used. Log-binomial regression with a generalized estimating equation approach was conducted to calculate risk ratios (RRs) and 95% confidence intervals (CIs) comparing the likelihood of self-reported illicit drug use during pregnancy (i.e., marijuana, synthetic marijuana, heroin, amphetamines, cocaine or crack, tranquilizers, or hallucinogens) among pregnant women in states with and without a punitive prenatal substance use policy. Analyses were conducted in spring 2025.</p><p><strong>Results: </strong>In multivariable analyses adjusted for potential confounders, the likelihood of illicit drug use during pregnancy did not differ between women in states with a punitive prenatal substance use policy and women in states without a punitive prenatal substance use policy (RR=1.02, 95% CI 0.93, 1.11).</p><p><strong>Conclusions: </strong>Results indicate illicit drug use during pregnancy does not differ in states with and without punitive state prenatal substance use policies, suggesting that these policies do not reduce substance use during pregnancy.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108155"},"PeriodicalIF":4.5,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Associations of partner cancer history with access to care among older adults in the U.S.","authors":"Freddie Yang, Kristin Litzelman, Xuesong Han, Zhiyuan Zheng, Xin Hu, K Robin Yabroff, Jingxuan Zhao","doi":"10.1016/j.amepre.2025.108152","DOIUrl":"https://doi.org/10.1016/j.amepre.2025.108152","url":null,"abstract":"<p><strong>Background: </strong>The long-term effects of individuals' cancer diagnosis and treatment may disrupt their partners' daily activities, employment, and financial stability, potentially impacting access to healthcare. This study aimed to examine the association of partner cancer history and access to care.</p><p><strong>Methods: </strong>Adults aged ≥50 years living with a partner who participated in the 2010-2022 Health and Retirement Study were included in this cross-sectional study. Individuals were categorized as with or without a partner with a cancer history. Access to care was measured as: 1) having a usual source of care, 2) difficulties finding a provider, 3) inability to afford medical care, and 4) receipt of preventive services, including flu vaccination, cholesterol checks, and any breast, colorectal, or cervical cancer screenings within the past 2 years. Multivariable logistic regression analyses were used to examine associations of partner cancer history and access to care, adjusted for age, sex, race and ethnicity, educational attainment, comorbidities, individual cancer history, and survey year.</p><p><strong>Results: </strong>Individuals whose partner had a cancer history had higher odds of reporting challenges in finding a general provider (odds ratio (OR): 1.30, 95% confidence interval (CI): 1.04-1.62) than individuals without partner cancer history. Partner cancer history was associated with a higher likelihood of receiving breast (1.34(1.07-1.68)) and colorectal (1.15(1.03-1.29)) cancer screenings among eligible populations.</p><p><strong>Conclusions: </strong>Programs aimed at improving resources are needed for individuals with a partner diagnosed with cancer. Partner's cancer diagnosis may also enhance individuals' awareness and uptake of cancer screenings.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108152"},"PeriodicalIF":4.5,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}